BAXTER INTERNATIONAL INC — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BAXTER INTERNATIONAL INC (BAX)
CIK: 0000010456
Period of Report: 2025-01-31

Reporting Person: Toth Christopher A. (EVP, Group Pres, Kidney Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-31	Common Stock, $1 par value	F	25372	$32.56	Disposed	105186	Direct

Footnotes

F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").

F2: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.